Notably, among these proteins, the levels of angiopoietin-related protein 3 (ANGPTL3), a protein known to be associated with cardiovascular disease (CVD) in the general population, decreased with statin therapy (6, 7). Here, ANGPTL3 is linked to cardiovascular disorder.